Cargando…
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
Macrophage activation syndrome (MAS) is a life-threatening complication of pediatric rheumatic diseases, occurring most commonly in children with systemic juvenile idiopathic arthritis (SJIA). Despite several classes of currently available treatment options for SJIA, including biologic agents target...
Autores principales: | Inoue, Natsumi, Schulert, Grant S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039518/ https://www.ncbi.nlm.nih.gov/pubmed/36964620 http://dx.doi.org/10.1186/s13075-023-03032-8 |
Ejemplares similares
-
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis
por: Macaraeg, Marci, et al.
Publicado: (2023) -
Differential monocyte microrna expression profiles in children with active systemic juvenile idiopathic arthritis
por: Schulert, Grant, et al.
Publicado: (2014) -
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
por: Ailioaie, Laura Marinela, et al.
Publicado: (2022) -
Proceedings from the 2(nd) Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
por: Canna, Scott W., et al.
Publicado: (2020) -
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)